Cropx Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets %
About Cropx Biotech
Cropx Biotech Private Limited (CBPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 August 2020 (Four years and six months 7 days old ). Its registered office is in Jodhpur, Rajasthan, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Kuldeep Peshwa and Anurag Bang serve as directors at the Company.
Company Details
- Location
Jodhpur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01110RJ2020PTC070379
- Company No.
070379
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Aug 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Cropx Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anurag Bang  | Director | 19-Aug-2020 | Current |
| Kuldeep Peshwa | Director | 19-Aug-2020 | Current |
Financial Performance of Cropx Biotech.
Cropx Biotech Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Cropx Biotech?
Unlock access to Cropx Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Aastha Suppliers Private LimitedKuldeep Peshwa is a mutual person
- Bothra Variant Private Limited
Kuldeep Peshwa is a mutual person
- Vedant Tie-Up Private Limited
Anurag Bang is a mutual person
- Bang Developers Private Limited
Anurag Bang is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cropx Biotech?
Cropx Biotech has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cropx Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cropx Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.